# FDA recall D-0341-2018

> **PD-Rx Pharmaceuticals, Inc.** · Class II · drug recall initiated 2018-01-25.

## Product

PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60

## Reason for recall

CGMP deviations.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0341-2018
- **Recalling firm:** PD-Rx Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-01-25
- **Report date:** 2018-02-07
- **Termination date:** 2020-05-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Oklahoma City, OK, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0341-2018

## Citation

> AI Analytics. FDA recall D-0341-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0341-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*